JPS5495570A - Hydantoin derivative therapeutic agent - Google Patents
Hydantoin derivative therapeutic agentInfo
- Publication number
- JPS5495570A JPS5495570A JP14592578A JP14592578A JPS5495570A JP S5495570 A JPS5495570 A JP S5495570A JP 14592578 A JP14592578 A JP 14592578A JP 14592578 A JP14592578 A JP 14592578A JP S5495570 A JPS5495570 A JP S5495570A
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- hydantoin derivative
- derivative therapeutic
- hydantoin
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73306276A | 1976-10-18 | 1976-10-18 | |
US000000733062 | 1976-10-18 | ||
US000000767803 | 1977-02-11 | ||
US05/767,803 US4117230A (en) | 1976-10-18 | 1977-02-11 | Hydantoin derivatives as therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5495570A true JPS5495570A (en) | 1979-07-28 |
JPS5940388B2 JPS5940388B2 (en) | 1984-09-29 |
Family
ID=27112515
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12437177A Granted JPS5353653A (en) | 1976-10-18 | 1977-10-17 | Hydantoin derivatives medicines |
JP53145925A Expired JPS5940388B2 (en) | 1976-10-18 | 1978-11-25 | Hydantoin derivative therapeutic agent |
JP53145926A Expired JPS607997B2 (en) | 1976-10-18 | 1978-11-25 | Hydantoin derivative therapeutic agent |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12437177A Granted JPS5353653A (en) | 1976-10-18 | 1977-10-17 | Hydantoin derivatives medicines |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53145926A Expired JPS607997B2 (en) | 1976-10-18 | 1978-11-25 | Hydantoin derivative therapeutic agent |
Country Status (29)
Country | Link |
---|---|
JP (3) | JPS5353653A (en) |
AR (1) | AR220901A1 (en) |
AT (1) | AT356136B (en) |
AU (1) | AU504978B2 (en) |
BG (1) | BG28847A3 (en) |
CA (1) | CA1088945A (en) |
CH (1) | CH625511A5 (en) |
DD (1) | DD131931A5 (en) |
DE (4) | DE2746244C2 (en) |
DK (1) | DK150302C (en) |
ES (1) | ES463267A1 (en) |
FI (1) | FI62307C (en) |
FR (1) | FR2367754A1 (en) |
GB (1) | GB1566171A (en) |
GR (1) | GR70201B (en) |
HK (1) | HK53881A (en) |
IE (1) | IE45805B1 (en) |
IL (1) | IL53094A0 (en) |
KE (1) | KE3167A (en) |
LU (1) | LU78330A1 (en) |
MX (1) | MX4899E (en) |
MY (1) | MY8200157A (en) |
NL (1) | NL167434C (en) |
NO (1) | NO148453C (en) |
NZ (1) | NZ185358A (en) |
PH (1) | PH15639A (en) |
PT (1) | PT67164B (en) |
SE (1) | SE437024B (en) |
YU (1) | YU40821B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
US4127665A (en) * | 1978-01-18 | 1978-11-28 | Pfizer Inc. | Thienohydantoin derivatives |
US4147797A (en) * | 1978-08-11 | 1979-04-03 | Pfizer Inc. | Spiro-furanohydantoin derivatives |
US4200642A (en) * | 1978-08-21 | 1980-04-29 | Pfizer Inc. | Spiro-oxazolidindiones |
US4181728A (en) * | 1978-11-16 | 1980-01-01 | Pfizer Inc. | Spiro-polycyclicimidazolidinedione derivatives |
US4181729A (en) * | 1979-03-21 | 1980-01-01 | Pfizer Inc. | Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
US4283409A (en) * | 1979-10-29 | 1981-08-11 | Pfizer Inc. | Imidazolone derivatives |
US4286098A (en) * | 1980-03-28 | 1981-08-25 | Pfizer Inc. | Process for the preparation of chiral hydantoins |
JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
DE3262294D1 (en) * | 1981-05-13 | 1985-03-28 | Ici Plc | Pharmaceutical compositions containing spiro succinimide derivatives |
JPS58213717A (en) * | 1982-01-20 | 1983-12-12 | Eisai Co Ltd | Remedy containing hydantoin derivative |
JPS59500617A (en) * | 1982-04-15 | 1984-04-12 | アルコン・ラボラトリ−ズ・インコ−ポレ−テッド | Hydantoin therapeutic agent |
SU1380610A3 (en) * | 1982-12-06 | 1988-03-07 | Пфайзер Инк. (Фирма) | Method of producing spiroheteroazolydindiones or pharmaceutically acceptable salts thereof |
US4474967A (en) * | 1983-04-27 | 1984-10-02 | Pfizer Inc. | 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione |
WO1986002647A1 (en) * | 1984-10-30 | 1986-05-09 | Pfizer Inc. | Spiro-heteroazolones for treatment of diabetes complications |
JPS61200991A (en) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | Novel spiro-3-heteroazolidine compound, production thereof, preventive and remedy for diabetic complication comprising same as active ingredient |
US4575507A (en) * | 1985-05-29 | 1986-03-11 | Pfizer Inc. | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
JPS6357588A (en) * | 1986-08-28 | 1988-03-12 | Sanwa Kagaku Kenkyusho Co Ltd | Hydantoin derivative, salt and, production thereof and preventing and treating, agent for diabetic complication |
HU204832B (en) * | 1987-09-04 | 1992-02-28 | Pfizer | Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same |
GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
WO2003088915A2 (en) | 2002-04-18 | 2003-10-30 | University Of Virginia Patent Foundation | Novel sodium channel blockers |
FR2955107B1 (en) | 2010-01-08 | 2012-03-02 | Servier Lab | NOVEL THIOCHROMAN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB818724A (en) * | 1956-10-18 | 1959-08-19 | Ici Ltd | Hydantoin derivatives |
DE1135915B (en) * | 1961-06-29 | 1962-09-06 | Asta Werke Ag Chem Fab | Process for the production of new, anticonvulsant spirohydantoins |
US3532744A (en) * | 1967-07-28 | 1970-10-06 | American Home Prod | 1- and 2-amino substituted indane and tetralene carboxylic acids |
US3821383A (en) | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
DE2449030A1 (en) * | 1974-10-11 | 1976-05-20 | Schering Ag | NEW PYRIDINE DERIVATIVES |
US4130714A (en) * | 1977-05-23 | 1978-12-19 | Pfizer Inc. | Hydantoin therapeutic agents |
-
1977
- 1977-09-30 CA CA287,868A patent/CA1088945A/en not_active Expired
- 1977-10-03 SE SE7711053A patent/SE437024B/en not_active IP Right Cessation
- 1977-10-04 GR GR54503A patent/GR70201B/el unknown
- 1977-10-05 NZ NZ185358A patent/NZ185358A/en unknown
- 1977-10-06 AU AU29431/77A patent/AU504978B2/en not_active Expired
- 1977-10-10 YU YU2442/77A patent/YU40821B/en unknown
- 1977-10-10 IL IL53094A patent/IL53094A0/en not_active IP Right Cessation
- 1977-10-14 DE DE2746244A patent/DE2746244C2/en not_active Expired
- 1977-10-14 PH PH20335A patent/PH15639A/en unknown
- 1977-10-14 FI FI773060A patent/FI62307C/en not_active IP Right Cessation
- 1977-10-14 DE DE2759543A patent/DE2759543C2/en not_active Expired
- 1977-10-14 DE DE2759927A patent/DE2759927C2/en not_active Expired
- 1977-10-14 DE DE2759542A patent/DE2759542C2/de not_active Expired
- 1977-10-15 ES ES463267A patent/ES463267A1/en not_active Expired
- 1977-10-17 IE IE2114/77A patent/IE45805B1/en not_active IP Right Cessation
- 1977-10-17 MX MX776490U patent/MX4899E/en unknown
- 1977-10-17 CH CH1262677A patent/CH625511A5/en not_active IP Right Cessation
- 1977-10-17 LU LU78330A patent/LU78330A1/en unknown
- 1977-10-17 PT PT67164A patent/PT67164B/en unknown
- 1977-10-17 DK DK461377A patent/DK150302C/en not_active IP Right Cessation
- 1977-10-17 GB GB43122/77A patent/GB1566171A/en not_active Expired
- 1977-10-17 NL NL7711358.A patent/NL167434C/en not_active IP Right Cessation
- 1977-10-17 NO NO773548A patent/NO148453C/en unknown
- 1977-10-17 JP JP12437177A patent/JPS5353653A/en active Granted
- 1977-10-17 FR FR7731216A patent/FR2367754A1/en active Granted
- 1977-10-18 BG BG037604A patent/BG28847A3/en unknown
- 1977-10-18 AR AR269623A patent/AR220901A1/en active
- 1977-10-18 AT AT745977A patent/AT356136B/en not_active IP Right Cessation
- 1977-10-18 DD DD7700201582A patent/DD131931A5/en unknown
-
1978
- 1978-11-25 JP JP53145925A patent/JPS5940388B2/en not_active Expired
- 1978-11-25 JP JP53145926A patent/JPS607997B2/en not_active Expired
-
1981
- 1981-10-09 KE KE3167A patent/KE3167A/en unknown
- 1981-11-05 HK HK538/81A patent/HK53881A/en unknown
-
1982
- 1982-12-30 MY MY157/82A patent/MY8200157A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA775907B (en) | Hydantoin derivatives as therapeutic agents | |
ZA782919B (en) | Hydantoin therapeutic agents | |
JPS5495570A (en) | Hydantoin derivative therapeutic agent | |
GB2000136B (en) | Therapeutic agents | |
GB2005248B (en) | Therapeutic agents | |
ZA782816B (en) | Therapeutic agents | |
GB2018134A (en) | Cerebral therapeutic agent | |
GB2000138B (en) | Therapeutic agents | |
GB2000131B (en) | Therapeutic agents | |
ZA767066B (en) | Fungicidal agents | |
JPS5369822A (en) | Pharmaceutical agent | |
GB2004876B (en) | Therapeutic agents | |
AU1655376A (en) | Fungicidal agents | |
ZA77776B (en) | Therapeutic agents | |
GB2007656B (en) | Therapeutic agents | |
ZA786184B (en) | Therapeutic agents | |
JPS5248665A (en) | Hydantoin derivatives | |
GB2000510B (en) | Therapeutic agents | |
JPS5321165A (en) | Imidazole derivative | |
JPS52130925A (en) | Mouthhthrough administrating agent for cattle | |
JPS5312834A (en) | Antiiviral agent for animals | |
DE2967199D1 (en) | Vegetative stigmata therapeutic agent | |
GB2010824B (en) | Therapeutic agents | |
JPS5379863A (en) | Imidazole derivative | |
JPS52118481A (en) | Therapeutic agents |